Last reviewed · How we verify

NCT04661046

Study on the Correlation Between Gene Mutation and TCM Syndrome Types in Metastatic Colorectal Cancer

Status unknown NA Last updated 9 December 2020
What this trial tests

NA trial testing Traditional Chinese Medicine in Gene Mutation-Related Cancer in 100 participants. Status unknown.

Timeline
30 November 2020
Primary endpoint
31 August 2022
31 August 2022

Quick facts

Lead sponsorShanghai University of Traditional Chinese Medicine
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment100
Start date30 November 2020
Primary completion31 August 2022
Estimated completion31 August 2022

Drugs / interventions tested

Conditions studied

Sponsor

Shanghai University of Traditional Chinese Medicine

Who can join

Adults 18 to 80, any sex, with Gene Mutation-Related Cancer or Traditional Chinese Medicine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To explore the correlation between gene mutations of metastatic colorectal cancer and TCM syndrome types based on Second-generation sequencing technology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Traditional Chinese Medicine

Trials testing the same drug.

Other recruiting trials for Gene Mutation-Related Cancer

Currently open trials in the same condition.

Other Shanghai University of Traditional Chinese Medicine trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04661046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing